Hoffmann G, Aramaki S, Blum-Hoffmann E, Nyhan WL, Sweetman L
Clinical research has indicated that FOXO4-DRI has shown promise in the following areas: Targets senescent cells FOXO4-DRI is a synthetic peptide designed to target senescent cells, which are damaged cells that stop dividing but resist apoptosis (programmed cell death)
Vitamin B12 injections are typically used to treat a deficiency in people who are unable to absorb adequate amounts of B12
Chemotherapy Recovery Improvement According to studies, chemotherapy drugs may cause cellular senescence in healthy tissues, which later secrete inflammatory factors that lead to chronic fatigue, organ dysfunction, and accelerated aging in cancer survivors
BPC-157's growth factor upregulation promotes satellite cell activation and myoblast proliferation, the cellular processes underlying muscle regeneration
Insulin resistance and inflammation are brought on by an excess of body fat leading to the occurrence of fat on the liver